This announcement is a separate document:
上海第一医药股份有限公司2024年第三季度报告
Shanghai First Pharmaceutical Co., Ltd. Report for the Third Quarter of 2024
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Latest
16:43
The performance of some domestic demand companies is expected to rebound according to Bank of America Securities, with CHINA FEIHE's rating upgraded to "Buy."
CHINA FEIHE+1.58%
16:40
Jefferies Financial: Raises ZTE's Target Price to HKD 18.58; Market Expectations for AI May Still Be Too High.
ZTE Corporation+1.81%
16:40
South Sudan's Minister of Oil: South Sudan will resume oil production on January 8, starting with an extraction of 0.09 million barrels of oil per day.
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.